206 related articles for article (PubMed ID: 9882797)
1. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
Bigatel DA; Elmore JR; Carey DJ; Cizmeci-Smith G; Franklin DP; Youkey JR
J Vasc Surg; 1999 Jan; 29(1):130-8; discussion 138-9. PubMed ID: 9882797
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).
Moore G; Liao S; Curci JA; Starcher BC; Martin RL; Hendricks RT; Chen JJ; Thompson RW
J Vasc Surg; 1999 Mar; 29(3):522-32. PubMed ID: 10069917
[TBL] [Abstract][Full Text] [Related]
3. Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
Nosoudi N; Nahar-Gohad P; Sinha A; Chowdhury A; Gerard P; Carsten CG; Gray BH; Vyavahare NR
Circ Res; 2015 Nov; 117(11):e80-9. PubMed ID: 26443597
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW
J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.
Petrinec D; Liao S; Holmes DR; Reilly JM; Parks WC; Thompson RW
J Vasc Surg; 1996 Feb; 23(2):336-46. PubMed ID: 8637112
[TBL] [Abstract][Full Text] [Related]
6. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW; Baxter BT
Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin suppresses experimental aortic aneurysm growth.
Lawrence DM; Singh RS; Franklin DP; Carey DJ; Elmore JR
J Vasc Surg; 2004 Aug; 40(2):334-8. PubMed ID: 15297830
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium channel blocker azelnidipine on experimental abdominal aortic aneurysms.
Yokokura H; Hiromatsu S; Akashi H; Kato S; Aoyagi S
Surg Today; 2007; 37(6):468-73. PubMed ID: 17522763
[TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
Parodi FE; Mao D; Ennis TL; Bartoli MA; Thompson RW
J Vasc Surg; 2005 Mar; 41(3):479-89. PubMed ID: 15838484
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.
Bergoeing MP; Arif B; Hackmann AE; Ennis TL; Thompson RW; Curci JA
J Vasc Surg; 2007 Jun; 45(6):1217-1227. PubMed ID: 17398058
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Di Sebastiano P; di Mola FF; Artese L; Rossi C; Mascetta G; Pernthaler H; Innocenti P
Digestion; 2001; 63(4):234-9. PubMed ID: 11435723
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
13. Effect of novel limited-spectrum MMP inhibitor XL784 in abdominal aortic aneurysms.
Ennis T; Jin J; Bartlett S; Arif B; Grapperhaus K; Curci JA
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):417-26. PubMed ID: 22894883
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion.
Johanning JM; Franklin DP; Han DC; Carey DJ; Elmore JR
J Vasc Surg; 2001 Mar; 33(3):579-86. PubMed ID: 11241130
[TBL] [Abstract][Full Text] [Related]
15. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
Liao S; Miralles M; Kelley BJ; Curci JA; Borhani M; Thompson RW
J Vasc Surg; 2001 May; 33(5):1057-64. PubMed ID: 11331849
[TBL] [Abstract][Full Text] [Related]
16. A novel rat model of abdominal aortic aneurysm using a combination of intraluminal elastase infusion and extraluminal calcium chloride exposure.
Tanaka A; Hasegawa T; Chen Z; Okita Y; Okada K
J Vasc Surg; 2009 Dec; 50(6):1423-32. PubMed ID: 19958989
[TBL] [Abstract][Full Text] [Related]
17. MF-tricyclic inhibits growth of experimental abdominal aortic aneurysms.
Keeling WB; Hackmann AE; Colter ME; Stone PA; Johnson BL; Back MR; Bandyk DF; Shames ML
J Surg Res; 2007 Aug; 141(2):192-5. PubMed ID: 17574591
[TBL] [Abstract][Full Text] [Related]
18. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms.
Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG
Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491
[TBL] [Abstract][Full Text] [Related]
19. Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats.
Bao W; Morimoto K; Hasegawa T; Sasaki N; Yamashita T; Hirata K; Okita Y; Okada K
J Vasc Surg; 2014 Apr; 59(4):1098-108. PubMed ID: 23790558
[TBL] [Abstract][Full Text] [Related]
20. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
